| Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 22883636 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: The aim of this study was to evaluate the links between connexin43 (Cx43) expression, myocardial conduction velocity, and ventricular tachycardia in a model of healed myocardial infarction. BACKGROUND: Post-infarction ventricular arrhythmias frequently cause sudden death. Impaired myocardial conduction has previously been linked to ventricular arrhythmias. Altered connexin expression is a potential source of conduction slowing identified in healed scar border tissues. The functional effect of increasing border-zone Cx43 has not been previously evaluated. METHODS: Twenty-five Yorkshire pigs underwent anterior infarction by transient left anterior descending coronary artery occlusion, followed by weekly testing for arrhythmia inducibility. Twenty animals with reproducibly inducible sustained monomorphic ventricular tachycardia were randomized 2:1:1 to receive AdCx43, Adβgal, or no gene transfer. One week later, animals underwent follow-up electrophysiologic study and tissue assessment for several functional and molecular measures. RESULTS: Animals receiving AdCx43 had less electrogram fractionation and faster conduction velocity in the anterior-septal border zone. Only 40% of AdCx43 animals remained inducible for ventricular tachycardia, while 100% of controls were inducible after gene transfer. AdCx43 animals had 2-fold higher Cx43 protein levels in the anterior-septal infarct border, with similar percents of phosphorylated and intercalated disk-localized Cx43 compared with controls. CONCLUSIONS: These data mechanistically link Cx43 expression to slow conduction and arrhythmia susceptibility in the healed scar border zone. Targeted manipulation of Cx43 levels improved conduction velocity and reduced ventricular tachycardia susceptibility. Cx43 gene transfer represents a novel treatment strategy for post-infarction arrhythmias. |
| | |
Authors:
|
Ian D Greener; Tetsuo Sasano; Xiaoping Wan; Tomonori Igarashi; Maria Strom; David S Rosenbaum; J Kevin Donahue |
Related Documents
:
|
7586336 - Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures... 12848696 - Assessment of myocardial perfusion with intravenous contrast echocardiography: comparis... 12695456 - Regional myocardial perfusion defects during exercise, as assessed by three dimensional... 21986506 - Biomarkers of left ventricular hypertrophy and remodeling in blacks. 3351146 - Measurement of left atrial systolic time intervals in hypertensive patients using doppl... 12845186 - Clinical outcome of percutaneous transluminal coronary rotational atherectomy in patien... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2012-08-08 |
Journal Detail:
|
Title: Journal of the American College of Cardiology Volume: 60 ISSN: 1558-3597 ISO Abbreviation: J. Am. Coll. Cardiol. Publication Date: 2012 Sep |
Date Detail:
|
Created Date: 2012-09-14 Completed Date: 2012-11-19 Revised Date: 2013-04-16 |
Medline Journal Info:
|
Nlm Unique ID: 8301365 Medline TA: J Am Coll Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 1103-10 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
Heart and Vascular Research Center, MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio 44109, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Connexin 43 / administration & dosage, genetics* Disease Susceptibility / metabolism, physiopathology, therapy Gene Transfer Techniques* Genetic Therapy / methods Heart Conduction System / metabolism, physiopathology Myocardial Infarction / complications, genetics*, therapy* Random Allocation Swine Tachycardia, Ventricular / etiology, genetics*, therapy* |
| Grant Support | |
ID/Acronym/Agency:
|
R01 EB002846/EB/NIBIB NIH HHS; R01 HL067148/HL/NHLBI NIH HHS; R01 HL093486/HL/NHLBI NIH HHS; R01HL67148/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Connexin 43 |
| Comments/Corrections | |
Comment In:
|
J Am Coll Cardiol. 2012 Sep 18;60(12):1111-3
[PMID:
22883635
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Longitudinal Left Ventricular Function for Prediction of Survival in Systemic Light-Chain Amyloidosi...
Next Document: Toxicity assessment and analgesic activity investigation of aqueous acetone extracts of Sida acuta ...